Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2002 > Volume 11 Number 4 July 2002 > DEVICE EVALUATION > Influence of Patient-Prosthesis Mismatch on Long-Term Results after Aortic Valve Replacement with a Stented Bioprosthesis

Influence of Patient-Prosthesis Mismatch on Long-Term Results after Aortic Valve Replacement with a Stented Bioprosthesis

Jean M. Frapier MD, Philippe Rouvière MD, Franck Razcka MD, Thierry Aymard MD, Bernard Albat MD, Paul A. Chaptal MD

The study aim was to evaluate the long-term effect of patient-prosthesis mismatch (effective orifice area/body surface area £0.85 cm2/m2) in a population of 90 consecutive patients who received an aortic Medtronic Intact valve either with (n = 64) or without (n = 26) mismatch. At 10 years postoperatively there was no significant inter-group difference in overall survival. By multivariate analysis, the main risk factor for late death was a left ventricular ejection fraction (LVEF) <50% (p =

0.0001). Freedom from cardiac death was not significantly different when LVEFs were paired between two groups. The NYHA functional status of survivors showed 94.4% of mismatch patients and 100% of no-mismatch patients to be in NYHA classes I and II (p = 1). Within this population, it was not possible to demonstrate negative effects of mismatch at 10 years after Intact bioprosthetic aortic valve replacement, and LVEF was the only predictor for late death.

Influence of Patient-Prosthesis Mismatch on Long-Term Results after Aortic Valve Replacement with a Stented Bioprosthesis

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

This article doesn't appear to be availble for purchase as a single artilce. Please contact us for further information.